Ken Fisher's position in Charles River Laboratories International is currently worth $42.9 Million. That's 0.02% of their equity portfolio (230th largest holding). The first Charles River Laboratories International trade was made in Q3 2013. Since then Ken Fisher bought shares sixteen more times and sold shares on 25 occasions. The stake costed the investor $15.4 Million, netting the investor a gain of 178% so far.
Transparency Market Research (TMR) has published a new report titled, Pyrogen Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and For...
OpenPR, over 2 years agoCell and Gene Therapy Manufacturing Services Market is projected to thrive at $13.8 Bn at CAGR +12% by the timeframe of 2021-28. Cell therapy manufacturing, ...
OpenPR, over 2 years agoQY Reports has released a new The Global Monocyte Activation Tests Market report provides information on market size, share, trends, growth, cost structure, ...
OpenPR, over 2 years agoCell & Gene Therapy Manufacturing Services Market: Overview The cell & gene therapy manufacturing services market is majorly driven by rising agreements and ...
OpenPR, over 2 years ago